Oncogenic activation of ERG: A predominant mechanism in prostate cancer

por Sreenath, Taduru L, Dobi, Albert, Petrovics, Gyorgy, Srivastava, Shiv
Publicado 2011

PMEPA1 Gene Isoforms: A Potential Biomarker and Therapeutic Target in Prostate Cancer

por Sharad, Shashwat, Dobi, Albert, Srivastava, Shiv, Srinivasan, Alagarsamy, Li, Hua
Publicado 2020

ERG Tumor Type is Less Frequent in High Grade and High Stage Prostate Cancers of Chinese Men

por Baohong, Jiang, Sedarsky, Jason, Srivastava, Shiv, Sesterhenn, Isabell, Dobi, Albert, Quanlin, Li
Publicado 2019

Hematological Toxicities with PARP Inhibitors in Prostate Cancer: A Systematic Review and Meta-Analysis of Phase II/III Randomized Controlled Trials

por Bowling, Gartrell C., Swargaloganathan, Piragash, Heintz, Carly, Madan, Ravi A., Eldhose, Binil, Dobi, Albert, Chesnut, Gregory T.
Publicado 2023

Prostate cancer gene expression signature of patients with high body mass index

por Sharad, Shashwat, Srivastava, Anjali, Ravulapalli, Suma, Parker, Patrick, Chen, Yongmei, Li, Hua, Petrovics, Gyorgy, Dobi, Albert
Publicado 2010

Loss of miR-449a in ERG-associated prostate cancer promotes the invasive phenotype by inducing SIRT1

por Kumar, Parameet, Sharad, Shashwat, Petrovics, Gyorgy, Mohamed, Ahmed, Dobi, Albert, Sreenath, Taduru L., Srivastava, Shiv, Biswas, Roopa
Publicado 2016

Loss of the NKX3.1 tumorsuppressor promotes the TMPRSS2-ERG fusion gene expression in prostate cancer

por Thangapazham, Rajesh, Saenz, Francisco, Katta, Shilpa, Mohamed, Ahmed A, Tan, Shyh-Han, Petrovics, Gyorgy, Srivastava, Shiv, Dobi, Albert
Publicado 2014

Increased Smad3 and reduced Smad2 levels mediate the functional switch of TGF-β from growth suppressor to growth and metastasis promoter through TMEPAI/PMEPA1 in triple negative br...

por Singha, Prajjal K., Pandeswara, Srilakshmi, Geng, Hui, Lan, Rongpei, Venkatachalam, Manjeri A., Dobi, Albert, Srivastava, Shiv, Saikumar, Pothana
Publicado 2019

Genomic alterations of Tenascin C in highly aggressive prostate cancer: a meta-analysis

por Mishra, Prachi, Kiebish, Michael A., Cullen, Jennifer, Srinivasan, Alagarsamy, Patterson, Aliyah, Sarangarajan, Rangaprasad, Narain, Niven R., Dobi, Albert
Publicado 2019

New Selective Inhibitors of ERG Positive Prostate Cancer: ERGi-USU-6 Salt Derivatives

por Eldhose, Binil, Pandrala, Mallesh, Xavier, Charles, Mohamed, Ahmed A., Srivastava, Shiv, Sunkara, Anu D., Dobi, Albert, Malhotra, Sanjay V.
Publicado 2021

Association of TP53 Single Nucleotide Polymorphisms with Prostate Cancer in a Racially Diverse Cohort of Men

por Duncan, Allison, Nousome, Darryl, Ricks, Randy, Kuo, Huai-Ching, Ravindranath, Lakshmi, Dobi, Albert, Cullen, Jennifer, Srivastava, Shiv, Chesnut, Gregory T., Petrovics, Gyorgy, Kohaar, Indu
Publicado 2023

Reconstitution of the ERG Gene Expression Network Reveals New Biomarkers and Therapeutic Targets in ERG Positive Prostate Tumors

por Dubovenko, Alexey, Serebryiskaya, Tatiana, Nikolsky, Yuri, Nikolskaya, Tatiana, Perlina, Ally, JeBailey, Lellean, Bureeva, Svetlana, Katta, Shilpa, Srivastava, Shiv, Dobi, Albert, Khasanova, Tatiana
Publicado 2015

Systematic analysis reveals molecular characteristics of ERG-negative prostate cancer

por Xiao, Qingyu, Sun, Yidi, Dobi, Albert, Srivastava, Shiv, Wang, Wendy, Srivastava, Sudhir, Ji, Yuan, Hou, Jun, Zhao, Guo-Ping, Li, Yixue, Li, Hong
Publicado 2018

Ets Family Protein, Erg Expression in Developing and Adult Mouse Tissues by a Highly Specific Monoclonal Antibody

por Mohamed, Ahmed A., Tan, Shyh-Han, Mikhalkevich, Natallia, Ponniah, Sathibalan, Vasioukhin, Valeri, Bieberich, Charles J., Sesterhenn, Isabell A., Dobi, Albert, Srivastava, Shiv, Sreenath, Taduru L.
Publicado 2010

Prostate cancer marker panel with single cell sensitivity in urine

por Nickens, Kristen P., Ali, Amina, Scoggin, Tatiana, Tan, Shyh‐Han, Ravindranath, Lakshmi, McLeod, David G., Dobi, Albert, Tacha, David, Sesterhenn, Isabell A., Srivastava, Shiv, Petrovics, Gyorgy
Publicado 2015

Silencing of PMEPA1 accelerates the growth of prostate cancer cells through AR, NEDD4 and PTEN

por Li, Hua, Mohamed, Ahmed A., Sharad, Shashwat, Umeda, Elizabeth, Song, Yingjie, Young, Denise, Petrovics, Gyorgy, McLeod, David G., Sesterhenn, Isabell A., Sreenath, Taduru, Dobi, Albert, Srivastava, Shiv
Publicado 2015

Analysis of PMEPA1 Isoforms (a and b) as Selective Inhibitors of Androgen and TGF-β Signaling Reveals Distinct Biological and Prognostic Features in Prostate Cancer

por Sharad, Shashwat, Sztupinszki, Zsófia M., Chen, Yongmei, Kuo, Claire, Ravindranath, Lakshmi, Szallasi, Zoltan, Petrovics, Gyorgy, Sreenath, Taduru L., Dobi, Albert, Rosner, Inger L., Srinivasan, Alagarsamy, Srivastava, Shiv, Cullen, Jennifer, Li, Hua
Publicado 2019

Age and Tumor Differentiation-Associated Gene Expression Based Analysis of Non-Familial Prostate Cancers

por Sharad, Shashwat, Allemang, Travis C., Li, Hua, Nousome, Darryl, Ku, Anson Tai, Whitlock, Nichelle C., Sowalsky, Adam G., Cullen, Jennifer, Sesterhenn, Isabell A., McLeod, David G., Srivastava, Shiv, Dobi, Albert
Publicado 2021

Methylation of the PMEPA1 gene, a negative regulator of the androgen receptor in prostate cancer

por Sharad, Shashwat, Ravindranath, Lakshmi, Haffner, Michael C, Li, Hua, Yan, Wusheng, Sesterhenn, Isabell A, Chen, Yongmei, Ali, Amina, Srinivasan, Alagarsamy, McLeod, David G, Yegnasubramanian, Srinivasan, Srivastava, Shiv, Dobi, Albert, Petrovics, Gyorgy
Publicado 2014

Functional antagonism of TMPRSS2-ERG splice variants in prostate cancer

por Rastogi, Anshu, Tan, Shyh-Han, Mohamed, Ahmed A., Chen, Yongmei, Hu, Ying, Petrovics, Gyorgy, Sreenath, Taduru, Kagan, Jacob, Srivastava, Sudhir, McLeod, David G., Sesterhenn, Isabell A., Srivastava, Shiv, Dobi, Albert, Srinivasan, Alagarsamy
Publicado 2014